Cann Group finance chief exits after four months by Steve Jones August 14, 2024January 13, 2025 Cann Group has parted ways with chief financial officer Tony Di Pietro after just four months […]
Cann Group confirms Jenni Pilcher as MD and CEO after drawing up ‘well-defined strategy’ by Steve Jones July 18, 2024November 25, 2024
Company news: Zelira Therapeutics; Ecofibre; Cann Group; InhaleRx; Argent Biopharma; Melodiol Global Health; Wellnex Life by Steve Jones July 4, 2024November 25, 2024
Company news: Clever Leaves; Cronos/Vitura; InhaleRX; Emyria; CannMart/Aura Therapeutics; Cann Group; Greenfern Industries; LGP/Reset Mind Sciences by Steve Jones and Martin Lane January 16, 2024July 11, 2024
Cann Group to target institutional investors after capital raise falls short by Steve Jones July 28, 2023April 30, 2024
Company news: Little Green Pharma; Cann Group; Melodiol Global Health; Entourage Health; Levin Health by Steve Jones and Martin Lane July 12, 2023April 30, 2024
Cann Group aims for profitability ‘within two years’ as revenue doubles in FY23 by Steve Jones July 5, 2023April 30, 2024
